Alphatec Holdings (ATEC) Liabilities and Shareholders Equity (2010 - 2026)
Alphatec Holdings (ATEC) reported Liabilities and Shareholders Equity of $799.5 million for Q1 2026, up 1.78% on a YoY basis from $785.5 million in Q1 2025, and up 1.05% sequentially from $791.2 million in Q4 2025.
Alphatec Holdings (ATEC) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $799.5 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 1.78% year-over-year to $799.5 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 billion (up 3.01% YoY), and the FY2025 full-year result was $791.2 million, up 2.0% from the prior year.
- Liabilities and Shareholders Equity advanced to $799.5 million in Q1 2026, from $791.2 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $805.2 million in Q4 2023 to a low of $511.9 million in Q2 2022.
- A 5-year average of $693.5 million and a median of $768.6 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity declined 13.68% in 2022 and jumped 54.56% in 2023, its largest moves.
- Tracing ATEC's Liabilities and Shareholders Equity over 5 years: stood at $521.0 million in 2022, then jumped by 54.56% to $805.2 million in 2023, then dropped by 3.66% to $775.7 million in 2024, then gained by 2.0% to $791.2 million in 2025, then grew by 1.05% to $799.5 million in 2026.
- Business Quant data shows ATEC's Liabilities and Shareholders Equity at $799.5 million in Q1 2026, $791.2 million in Q4 2025, and $787.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | 799.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 799.48 Mn |
| Dec 31, 2025 | 791.21 Mn |
| Sep 30, 2025 | 787.25 Mn |
| Jun 30, 2025 | 790.29 Mn |
| Mar 31, 2025 | 785.47 Mn |
| Dec 31, 2024 | 775.71 Mn |
| Sep 30, 2024 | 745.90 Mn |
| Jun 30, 2024 | 768.59 Mn |
| Mar 31, 2024 | 774.58 Mn |
| Dec 31, 2023 | 805.21 Mn |
| Sep 30, 2023 | 670.22 Mn |
| Jun 30, 2023 | 628.23 Mn |
| Mar 31, 2023 | 569.69 Mn |
| Dec 31, 2022 | 520.97 Mn |
| Sep 30, 2022 | 516.28 Mn |
| Jun 30, 2022 | 511.94 Mn |
| Mar 31, 2022 | 548.69 Mn |
| Dec 31, 2021 | 572.05 Mn |
| Sep 30, 2021 | 598.11 Mn |
| Jun 30, 2021 | 441.03 Mn |